PureTech Health Financials
| PRTC Stock | USD 16.80 0.39 2.27% |
Please note, the presentation of PureTech Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, PureTech Health's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of PureTech Health's management manipulating its earnings.
PureTech Health Stock Summary
PureTech Health competes with Autolus Therapeutics, Neurogene, Solid Biosciences, QuantumSi, and Lineage Cell. PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts. PureTech Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 95 people.| Foreign Associate | UK |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US7462371060 |
| Business Address | 6 Tide Street, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.puretechhealth.com |
| Phone | 617 482 2333 |
| Currency | USD - US Dollar |
PureTech Health Key Financial Ratios
| Return On Equity | 0.0944 | ||||
| Return On Asset | -0.13 | ||||
| Target Price | 46.0 | ||||
| Number Of Employees | 56 | ||||
| Beta | 0.69 |
PureTech Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining PureTech Health's current stock value. Our valuation model uses many indicators to compare PureTech Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PureTech Health competition to find correlations between indicators driving PureTech Health's intrinsic value. More Info.PureTech Health PLC is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PureTech Health's earnings, one of the primary drivers of an investment's value.About PureTech Health Financials
What exactly are PureTech Health Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include PureTech Health's income statement, its balance sheet, and the statement of cash flows. Potential PureTech Health investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although PureTech Health investors may use each financial statement separately, they are all related. The changes in PureTech Health's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on PureTech Health's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.PureTech Health March 6, 2026 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of PureTech Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of PureTech Health PLC. We use our internally-developed statistical techniques to arrive at the intrinsic value of PureTech Health PLC based on widely used predictive technical indicators. In general, we focus on analyzing PureTech Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build PureTech Health's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.79 | |||
| Information Ratio | 0.0176 | |||
| Maximum Drawdown | 15.3 | |||
| Value At Risk | (3.57) | |||
| Potential Upside | 3.63 |
Complementary Tools for PureTech Stock analysis
When running PureTech Health's price analysis, check to measure PureTech Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PureTech Health is operating at the current time. Most of PureTech Health's value examination focuses on studying past and present price action to predict the probability of PureTech Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PureTech Health's price. Additionally, you may evaluate how the addition of PureTech Health to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |